Harbour BioMed Company

Harbour BioMed (HKEX: 02142.HK) is a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on oncology and immunology.
Technology: Others
Industry: Loss of Proteostasis
Headquarters: China
Founded Date: 2016
Employees Number: 51-100
Funding Status: Late Stage Venture
Estimated Revenue: $10M to $50M

Visit Website
Register and Claim Ownership